Retirement
ao. Univ.- Prof. Mag. Dr. Oskar Hoffmann
room: 2D176
tel: +43 1 4277 55340
e-mail: oskar.hoffmann@univie.ac.at
Mao Q, Hoffmann O, Yu K, Lu F, Lan G, Dai F et al. Self-contracting oxidized starch/gelatin hydrogel for noninvasive wound closure and wound healing. Materials & Design. 2020 Jul 6;194. 108916. doi.org/10.1016/j.matdes.2020.108916
Vidal L, Kampleitner C, Krissian S, Brennan MÁ, Hoffmann O, Raymond Y et al. Regeneration of segmental defects in metatarsus of sheep with vascularized and customized 3D-printed calcium phosphate scaffolds. Scientific Reports. 2020 Apr 27;10(1). 7068. doi.org/10.1038/s41598-020-63742-w
Kampleitner C, Changi K, Felfel RM, Scotchford CA, Sottile V, Kluger R et al. Preclinical biological and physicochemical evaluation of two-photon engineered 3D biomimetic copolymer scaffolds for bone healing. Biomaterials Science. 2020 Mär 17;8(6):1683-1694. doi.org/10.1039/c9bm01827a
Kampleitner C, Obi J, Vassilev N, Epstein MM, Hoffmann O. Biological Compatibility Profile on Biomaterials for Bone Regeneration. Journal of Visualized Experiments. 2018 Nov 16;141. e58077. doi.org/10.3791/58077
Changi K, Bosnjak B, Gonzalez-Obeso C, Kluger R, Rodríguez-Cabello JC, Hoffmann O et al. Biocompatibility and immunogenicity of elastin-like recombinamer biomaterials in mouse models. Journal of Biomedical Materials Research. Part A. 2018 Apr;106(4):924–934. doi.org/10.1002/jbm.a.36290
Xie R, Hu J, Hoffmann O, Zhang Y, Ng F, Qin T et al. Self-fitting shape memory polymer foam inducing bone regeneration: A rabbit femoral defect study. Biochimica et Biophysica Acta - General Subjects. 2018 Apr;1862(4):936-945. doi.org/10.1016/j.bbagen.2018.01.013
Fowler T, Kampleitner C, Poocza L, Markus A, Dullin C, Hildebrand G et al. Development and characterisation of novel biodegradable scaffold materials.. 2014. Postersitzung präsentiert bei 41st European Calcified Tissue Society Congress (ECTS 2014 ), Prag, Tschechische Republik.
Fowler T, Kampleitner C, Poocza L, Markus A, Dullin C, Hildebrand G et al. Pre-clinical screening of novel two-photon photopolymerised biomaterials for bone implantation.. 2014. Postersitzung präsentiert bei American Society for Bone and Mineral Research , Houston, USA / Vereinigte Staaten.
Markovic M, Van Hoorick J, Van Vlierberghe S, Fowler T, Hoffmann O, Dubruel P et al. Seeding 3D CAD scaffolds with photopolymerizable cell-hydrogel suspension.. 2014. Postersitzung präsentiert bei Tissue Engineering and Regenerative Medicine International Society Asia-Pacific, Daegu, Südkorea.
Van Hoorick J, Markovic M, Ovsianikov A, Fowler T, Hoffmann O, Dubruel P et al. Tuning the 3D Architecture of Hydrogel-Polyester Combinatory Scaffolds.. 2014. Postersitzung präsentiert bei European Society of Biomaterials, Liverpool, Großbritannien / Vereinigtes Königreich.
Lewis K, Zimmer G, Rohrhofer A, Hoffmann O. Resorption Capacity of Osteoclasts Predefined by Surface Porosity of Ceramic Biomaterials. 2012. Postersitzung präsentiert bei Annual Meeting of the American Society for Bone and Mineral Research, Minneapolis, USA / Vereinigte Staaten.
Zimmer G, Berger B, Hoffmann O, Gössl A. Strontium and calcium ions as liquid supplementation in cell culture media do not exert the same inhibitory effect on osteoclastic resorption capacity as the same ions released from strontium containing calcium-phosphate/carbonate powder. Journal of Tissue Engineering and Regenerative Medicine. 2012;6(SI, Suppl. 1):36-36.
Zimmer G, Rohrhofer A, Hoffmann O. THE SURFACE POROSITY OF CERAMIC BIOMATERIALS PREDEFINES THE ACTIVITY AND RESORPTION CAPACITY OF OSTEOCLASTS. Osteoporosis International. 2012;23(Suppl. 2):369-369.
Zimmer G, Berger B, Hoffmann O, Gössl A. STRONTIUM CONDITIONED MEDIA INHIBIT OSTEOCLASTOGENESIS ON DENTIN SLICES. Osteoporosis International. 2011;22(1):28-28.
Tedjiotsop Feudjio F, Dornetshuber-Fleiss R, Lemmens M, Hoffmann O, Lemmens R, Berger W. Beauvericin and enniatin. emerging toxins and/or remedies? World Mycotoxin Journal. 2010;3(4):415-430. doi.org/10.3920/WMJ2010.1245
Towle I, Johnson BJ, Hoffmann O, Hudson SA. Clinical guideline adherence in the primary care management of osteoporosis. 2009. Postersitzung präsentiert bei European Symposium on Clinical Pharmacy, Genf, Schweiz.
Binder N, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig T et al. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nature Medicine. 2009.
Hoffmann O, Lemmens R. The fungal secondary metabolites beauvericin and enniatin differentially regulate osteoclast inhibition during differentiation and bone resorption. Bone. 2009;44(2):327-327.
Hoffmann O. The fungal secondary metabolites beauvericin and enniatin inhibit osteoclast differentiation and bone resorption. Unknown Journal. 2008.
Johnson BJ, Towle I, Hoffmann O, Hudson SA. The implementation of evidence-based practice in osteoporosis treatment and prevention: development of a medication assessment tool: The implementation of evidence-based practice in osteoporosis treatment and prevention: development of a medication assessment tool. 2008. Postersitzung präsentiert bei 37th European Symposium on Clinical Pharmacy, Dubrovnik, Kroatien.